Climb Bio, Inc.: Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
Climb Bio, Inc. (Nasdaq: CLYM) announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson is an accomplished ...
Climb Bio appoints Perrin Wilson as CBO
Climb Bio (CLYM) announced the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Before joining Climb Bio, Dr. Wilson served as ...
Climb Bio任命新首席商务官，股价目标定为10美元
马萨诸塞州韦尔斯利希尔斯讯 - 市值1.02亿美元的临床阶段生物科技公司Climb Bio, Inc. (NASDAQ: CLYM )宣布任命Perrin Wilson博士为新任首席商务官。Wilson博士在制药和生物科技行业拥有超过17年的经验，将加入公司管理团队，负责领导商业化前期规划、沟通和业务发展工作。
Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
Climb Bio, Inc. (Nasdaq: CLYM) announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson ...